![conference banner](/images/conference-banner.jpeg)
Abstract
Background: The outbreak of coronavirus disease (COVID-19) has posed a major threat to people's lives across the globe. It has drastically changed the way we perceive this world. A paradigm shift was observed globally as the world’s emphasis shifted to testing, diagnosis, treatment, and developing a coronavirus cure. Clinical trials were also not untouched by this. The coronavirus pandemic has abhorrently affected the day-to-day clinical trial activities at sites.
Methods: The status of various ongoing clinical trials was assessed through a literature search, which also includes clinical trial portals. Our evaluations were based on these observations.
Results: Multiple challenges were present in clinical trials as recruitment, retention, the safety of trial subjects, protocol compliance, and this made the world to re-think to incorporate newer strategies and to cope with this untoward situation.
Conclusion: Digitalization of clinical trials as virtual management of adverse events, remote monitoring visits, and web-based consulting with trial subjects are potential directions that can be applied to better manage clinical trials worldwide.
Keywords: Clinical trials, challenges, coronavirus, COVID-19, strategies, digitalization.
[http://dx.doi.org/10.1038/s41579-018-0118-9] [PMID: 30531947]
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105924] [PMID: 32081636]
[http://dx.doi.org/10.4103/picr.PICR_77_20] [PMID: 32670829]
[http://dx.doi.org/10.1056/NEJMp2019989]
[http://dx.doi.org/10.4103/ijo.IJO_843_20] [PMID: 32317432]
[http://dx.doi.org/10.1177/1740774507087554] [PMID: 18283080]
[http://dx.doi.org/10.19080/CTBEB.2017.09.555771]
[http://dx.doi.org/10.3201/eid1003.030702] [PMID: 15109402]
![Wayfinder Image](/images/wayfinder.jpg)